CN102935185B - 一种用于治疗神经衰弱的丸剂及制备方法 - Google Patents
一种用于治疗神经衰弱的丸剂及制备方法 Download PDFInfo
- Publication number
- CN102935185B CN102935185B CN201210483874.8A CN201210483874A CN102935185B CN 102935185 B CN102935185 B CN 102935185B CN 201210483874 A CN201210483874 A CN 201210483874A CN 102935185 B CN102935185 B CN 102935185B
- Authority
- CN
- China
- Prior art keywords
- parts
- portions
- pill
- radix
- cortex
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000006187 pill Substances 0.000 title claims abstract description 28
- 238000002360 preparation method Methods 0.000 title claims abstract description 9
- 206010003549 asthenia Diseases 0.000 title abstract description 13
- 208000007443 Neurasthenia Diseases 0.000 title abstract description 10
- 238000011282 treatment Methods 0.000 claims abstract description 16
- 241000209140 Triticum Species 0.000 claims abstract description 15
- 235000021307 Triticum Nutrition 0.000 claims abstract description 15
- 239000002994 raw material Substances 0.000 claims abstract description 10
- 241000220433 Albizia Species 0.000 claims abstract description 7
- 235000004347 Perilla Nutrition 0.000 claims abstract description 7
- 210000000582 semen Anatomy 0.000 claims description 28
- 239000000843 powder Substances 0.000 claims description 22
- 238000007654 immersion Methods 0.000 claims description 19
- 241000217407 Margaritifera Species 0.000 claims description 14
- 239000004615 ingredient Substances 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 235000011438 Albizia odoratissima Nutrition 0.000 claims description 6
- 241000229722 Perilla <angiosperm> Species 0.000 claims description 6
- 241001530126 Scrophularia Species 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 5
- 238000012545 processing Methods 0.000 claims description 5
- 238000001816 cooling Methods 0.000 claims description 4
- 235000014121 butter Nutrition 0.000 claims description 3
- 235000013339 cereals Nutrition 0.000 claims description 3
- 238000004108 freeze drying Methods 0.000 claims description 3
- 235000012907 honey Nutrition 0.000 claims description 3
- 238000010298 pulverizing process Methods 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 239000003814 drug Substances 0.000 abstract description 30
- 210000004185 liver Anatomy 0.000 abstract description 24
- 210000000952 spleen Anatomy 0.000 abstract description 21
- 230000000694 effects Effects 0.000 abstract description 17
- 230000006870 function Effects 0.000 abstract description 8
- 230000001914 calming effect Effects 0.000 abstract description 6
- 210000005036 nerve Anatomy 0.000 abstract description 5
- 238000005728 strengthening Methods 0.000 abstract description 2
- 238000012795 verification Methods 0.000 abstract description 2
- 244000223760 Cinnamomum zeylanicum Species 0.000 abstract 1
- 244000247747 Coptis groenlandica Species 0.000 abstract 1
- 235000002991 Coptis groenlandica Nutrition 0.000 abstract 1
- 240000004670 Glycyrrhiza echinata Species 0.000 abstract 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 abstract 1
- 241000234435 Lilium Species 0.000 abstract 1
- 240000002853 Nelumbo nucifera Species 0.000 abstract 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 abstract 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 abstract 1
- 244000124853 Perilla frutescens Species 0.000 abstract 1
- 241001522129 Pinellia Species 0.000 abstract 1
- 244000081426 Ranunculus ficaria Species 0.000 abstract 1
- 235000002226 Ranunculus ficaria Nutrition 0.000 abstract 1
- 240000001341 Reynoutria japonica Species 0.000 abstract 1
- 235000018167 Reynoutria japonica Nutrition 0.000 abstract 1
- 235000017276 Salvia Nutrition 0.000 abstract 1
- 240000007164 Salvia officinalis Species 0.000 abstract 1
- 206010043268 Tension Diseases 0.000 abstract 1
- 241000157352 Uncaria Species 0.000 abstract 1
- 238000010521 absorption reaction Methods 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 235000017803 cinnamon Nutrition 0.000 abstract 1
- 238000009499 grossing Methods 0.000 abstract 1
- 229940010454 licorice Drugs 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 230000007721 medicinal effect Effects 0.000 abstract 1
- 235000008113 selfheal Nutrition 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 17
- 210000004369 blood Anatomy 0.000 description 16
- 208000002193 Pain Diseases 0.000 description 11
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 11
- 206010022437 insomnia Diseases 0.000 description 11
- 230000036407 pain Effects 0.000 description 11
- 239000007789 gas Substances 0.000 description 10
- 235000009508 confectionery Nutrition 0.000 description 9
- 238000012790 confirmation Methods 0.000 description 9
- 230000007812 deficiency Effects 0.000 description 9
- 210000002784 stomach Anatomy 0.000 description 9
- 206010007247 Carbuncle Diseases 0.000 description 8
- 210000004072 lung Anatomy 0.000 description 8
- 206010033557 Palpitations Diseases 0.000 description 7
- 210000003734 kidney Anatomy 0.000 description 7
- 206010011224 Cough Diseases 0.000 description 6
- 206010037660 Pyrexia Diseases 0.000 description 6
- 230000017531 blood circulation Effects 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 231100000614 poison Toxicity 0.000 description 6
- 230000002936 tranquilizing effect Effects 0.000 description 6
- 206010010904 Convulsion Diseases 0.000 description 5
- 206010012735 Diarrhoea Diseases 0.000 description 5
- 206010062717 Increased upper airway secretion Diseases 0.000 description 5
- 230000009471 action Effects 0.000 description 5
- 230000036461 convulsion Effects 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 210000000232 gallbladder Anatomy 0.000 description 5
- 230000001717 pathogenic effect Effects 0.000 description 5
- 208000026435 phlegm Diseases 0.000 description 5
- 239000002574 poison Substances 0.000 description 5
- 208000011580 syndromic disease Diseases 0.000 description 5
- 206010061218 Inflammation Diseases 0.000 description 4
- 206010022998 Irritability Diseases 0.000 description 4
- 208000031971 Yin Deficiency Diseases 0.000 description 4
- 230000036772 blood pressure Effects 0.000 description 4
- 208000002173 dizziness Diseases 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 241000411851 herbal medicine Species 0.000 description 4
- 244000052769 pathogen Species 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 230000035900 sweating Effects 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 208000006820 Arthralgia Diseases 0.000 description 3
- 208000000059 Dyspnea Diseases 0.000 description 3
- 206010013975 Dyspnoeas Diseases 0.000 description 3
- 208000036119 Frailty Diseases 0.000 description 3
- 208000001431 Psychomotor Agitation Diseases 0.000 description 3
- 206010038743 Restlessness Diseases 0.000 description 3
- 208000009205 Tinnitus Diseases 0.000 description 3
- 206010047700 Vomiting Diseases 0.000 description 3
- 238000004873 anchoring Methods 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 239000003146 anticoagulant agent Substances 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 235000019197 fats Nutrition 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 208000013403 hyperactivity Diseases 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 201000007227 lymph node tuberculosis Diseases 0.000 description 3
- 239000002398 materia medica Substances 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 231100000862 numbness Toxicity 0.000 description 3
- 231100000886 tinnitus Toxicity 0.000 description 3
- 230000001256 tonic effect Effects 0.000 description 3
- 210000001835 viscera Anatomy 0.000 description 3
- KWGRBVOPPLSCSI-WPRPVWTQSA-N (-)-ephedrine Chemical compound CN[C@@H](C)[C@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WPRPVWTQSA-N 0.000 description 2
- 208000019901 Anxiety disease Diseases 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 206010012289 Dementia Diseases 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 241000371997 Eriocheir sinensis Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 206010015958 Eye pain Diseases 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- WWNNZCOKKKDOPX-UHFFFAOYSA-N N-methylnicotinate Chemical compound C[N+]1=CC=CC(C([O-])=O)=C1 WWNNZCOKKKDOPX-UHFFFAOYSA-N 0.000 description 2
- 206010029333 Neurosis Diseases 0.000 description 2
- 206010033799 Paralysis Diseases 0.000 description 2
- 206010039897 Sedation Diseases 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 206010043458 Thirst Diseases 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000000954 anitussive effect Effects 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000001773 anti-convulsant effect Effects 0.000 description 2
- -1 antibacterial Substances 0.000 description 2
- 230000004596 appetite loss Effects 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 208000013116 chronic cough Diseases 0.000 description 2
- 230000000916 dilatatory effect Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 230000000147 hypnotic effect Effects 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 208000019423 liver disease Diseases 0.000 description 2
- 208000019017 loss of appetite Diseases 0.000 description 2
- 235000021266 loss of appetite Nutrition 0.000 description 2
- 206010025482 malaise Diseases 0.000 description 2
- 208000004396 mastitis Diseases 0.000 description 2
- 230000003340 mental effect Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 210000000653 nervous system Anatomy 0.000 description 2
- 208000015238 neurotic disease Diseases 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 230000036280 sedation Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- PGOHTUIFYSHAQG-LJSDBVFPSA-N (2S)-6-amino-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-1-[(2S,3R)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-4-methylsulfanylbutanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-5-carbamimidamidopentanoyl]amino]propanoyl]pyrrolidine-2-carbonyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]acetyl]amino]-3-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]-3-sulfanylpropanoyl]amino]-4-methylsulfanylbutanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-hydroxybutanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-hydroxypropanoyl]amino]-3-hydroxypropanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-4-methylpentanoyl]amino]-3-hydroxybutanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-5-carbamimidamidopentanoyl]amino]-5-oxopentanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxypropanoyl]amino]-3-carboxypropanoyl]amino]-3-hydroxypropanoyl]amino]-5-oxopentanoyl]amino]-5-oxopentanoyl]amino]-3-phenylpropanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]-4-oxobutanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-4-carboxybutanoyl]amino]-5-oxopentanoyl]amino]hexanoic acid Chemical compound CSCC[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(O)=O PGOHTUIFYSHAQG-LJSDBVFPSA-N 0.000 description 1
- SDOFMBGMRVAJNF-KVTDHHQDSA-N (2r,3r,4r,5r)-6-aminohexane-1,2,3,4,5-pentol Chemical compound NC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO SDOFMBGMRVAJNF-KVTDHHQDSA-N 0.000 description 1
- KJPRLNWUNMBNBZ-QPJJXVBHSA-N (E)-cinnamaldehyde Chemical compound O=C\C=C\C1=CC=CC=C1 KJPRLNWUNMBNBZ-QPJJXVBHSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010054196 Affect lability Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 208000031091 Amnestic disease Diseases 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- VWDXGKUTGQJJHJ-UHFFFAOYSA-N Catenarin Natural products C1=C(O)C=C2C(=O)C3=C(O)C(C)=CC(O)=C3C(=O)C2=C1O VWDXGKUTGQJJHJ-UHFFFAOYSA-N 0.000 description 1
- 206010008342 Cervix carcinoma Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 206010053567 Coagulopathies Diseases 0.000 description 1
- 208000002881 Colic Diseases 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 206010010144 Completed suicide Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010011469 Crying Diseases 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010057315 Daydreaming Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 239000010282 Emodin Substances 0.000 description 1
- RBLJKYCRSCQLRP-UHFFFAOYSA-N Emodin-dianthron Natural products O=C1C2=CC(C)=CC(O)=C2C(=O)C2=C1CC(=O)C=C2O RBLJKYCRSCQLRP-UHFFFAOYSA-N 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 108010088842 Fibrinolysin Proteins 0.000 description 1
- 241000881853 Galaxias maculatus Species 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 206010018498 Goitre Diseases 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- YOOXNSPYGCZLAX-UHFFFAOYSA-N Helminthosporin Natural products C1=CC(O)=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O YOOXNSPYGCZLAX-UHFFFAOYSA-N 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000004356 Hysteria Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 201000008197 Laryngitis Diseases 0.000 description 1
- 206010024419 Libido decreased Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 206010027940 Mood altered Diseases 0.000 description 1
- 208000005647 Mumps Diseases 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 208000002454 Nasopharyngeal Carcinoma Diseases 0.000 description 1
- 206010061306 Nasopharyngeal cancer Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- QGMRQYFBGABWDR-UHFFFAOYSA-M Pentobarbital sodium Chemical compound [Na+].CCCC(C)C1(CC)C(=O)NC(=O)[N-]C1=O QGMRQYFBGABWDR-UHFFFAOYSA-M 0.000 description 1
- 206010034960 Photophobia Diseases 0.000 description 1
- 108010068736 Pinellia ternata lectin Proteins 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- NTGIIKCGBNGQAR-UHFFFAOYSA-N Rheoemodin Natural products C1=C(O)C=C2C(=O)C3=CC(O)=CC(O)=C3C(=O)C2=C1O NTGIIKCGBNGQAR-UHFFFAOYSA-N 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 206010067868 Skin mass Diseases 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 102000002262 Thromboplastin Human genes 0.000 description 1
- 108010000499 Thromboplastin Proteins 0.000 description 1
- 206010044302 Tracheitis Diseases 0.000 description 1
- 102000003929 Transaminases Human genes 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- AXMVYSVVTMKQSL-UHFFFAOYSA-N UNPD142122 Natural products OC1=CC=C(C=CC=O)C=C1O AXMVYSVVTMKQSL-UHFFFAOYSA-N 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 206010046543 Urinary incontinence Diseases 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000006986 amnesia Effects 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000003556 anti-epileptic effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000000702 anti-platelet effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 210000003710 cerebral cortex Anatomy 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 201000010881 cervical cancer Diseases 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 229940117916 cinnamic aldehyde Drugs 0.000 description 1
- KJPRLNWUNMBNBZ-UHFFFAOYSA-N cinnamic aldehyde Natural products O=CC=CC1=CC=CC=C1 KJPRLNWUNMBNBZ-UHFFFAOYSA-N 0.000 description 1
- WJSDHUCWMSHDCR-VMPITWQZSA-N cinnamyl acetate Natural products CC(=O)OC\C=C\C1=CC=CC=C1 WJSDHUCWMSHDCR-VMPITWQZSA-N 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 208000012839 conversion disease Diseases 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000003001 depressive effect Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000009429 distress Effects 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- RHMXXJGYXNZAPX-UHFFFAOYSA-N emodin Chemical compound C1=C(O)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O RHMXXJGYXNZAPX-UHFFFAOYSA-N 0.000 description 1
- VASFLQKDXBAWEL-UHFFFAOYSA-N emodin Natural products OC1=C(OC2=C(C=CC(=C2C1=O)O)O)C1=CC=C(C=C1)O VASFLQKDXBAWEL-UHFFFAOYSA-N 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229960002179 ephedrine Drugs 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 201000003872 goiter Diseases 0.000 description 1
- 230000010247 heart contraction Effects 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 231100000753 hepatic injury Toxicity 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 238000009169 immunotherapy Methods 0.000 description 1
- 150000002475 indoles Chemical class 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000011221 initial treatment Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 229930182489 iridoid glycoside Natural products 0.000 description 1
- 150000008145 iridoid glycosides Chemical class 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 230000004199 lung function Effects 0.000 description 1
- GVALZJMUIHGIMD-UHFFFAOYSA-H magnesium phosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O GVALZJMUIHGIMD-UHFFFAOYSA-H 0.000 description 1
- 239000004137 magnesium phosphate Substances 0.000 description 1
- 229910000157 magnesium phosphate Inorganic materials 0.000 description 1
- 229960002261 magnesium phosphate Drugs 0.000 description 1
- 235000010994 magnesium phosphates Nutrition 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 210000004914 menses Anatomy 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000001617 migratory effect Effects 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 208000010805 mumps infectious disease Diseases 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 201000011216 nasopharynx carcinoma Diseases 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 230000008035 nerve activity Effects 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000000422 nocturnal effect Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 229960002275 pentobarbital sodium Drugs 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 229960002511 phenobarbital sodium Drugs 0.000 description 1
- WRLGYAWRGXKSKG-UHFFFAOYSA-M phenobarbital sodium Chemical compound [Na+].C=1C=CC=CC=1C1(CC)C(=O)NC([O-])=NC1=O WRLGYAWRGXKSKG-UHFFFAOYSA-M 0.000 description 1
- FFWOKTFYGVYKIR-UHFFFAOYSA-N physcion Chemical compound C1=C(C)C=C2C(=O)C3=CC(OC)=CC(O)=C3C(=O)C2=C1O FFWOKTFYGVYKIR-UHFFFAOYSA-N 0.000 description 1
- PKUBGLYEOAJPEG-UHFFFAOYSA-N physcion Natural products C1=C(C)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O PKUBGLYEOAJPEG-UHFFFAOYSA-N 0.000 description 1
- OISYIJRGMYJBRH-UHFFFAOYSA-N physcione Natural products COc1cc(O)c2C(=O)c3ccc(O)cc3C(=O)c2c1 OISYIJRGMYJBRH-UHFFFAOYSA-N 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 229940012957 plasmin Drugs 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 208000023482 precordial pain Diseases 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000002423 protozoacide Substances 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 230000004799 sedative–hypnotic effect Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 208000012201 sexual and gender identity disease Diseases 0.000 description 1
- 208000015891 sexual disease Diseases 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- JHJLBTNAGRQEKS-UHFFFAOYSA-M sodium bromide Inorganic materials [Na+].[Br-] JHJLBTNAGRQEKS-UHFFFAOYSA-M 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 230000003393 splenic effect Effects 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 210000000225 synapse Anatomy 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 230000002537 thrombolytic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 238000002834 transmittance Methods 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 239000002918 waste heat Substances 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 208000016261 weight loss Diseases 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种用于治疗神经衰弱的丸剂及制备方法,属中药领域。本发明药物有效成分的原料组成及重量份数为:甘草45~65份、法半夏45~60份、百合40~60份、玄参35~55份、黄莲35~50份、紫苏叶30~50份、合欢皮30~45份、莲肉25~45份、丹参25~40份、夜交藤20~40份、淮小麦20~35份、珍珠母20~30份、夏枯草15~30份、肉桂15~25份、酸枣仁10~25份、钩藤5~20份。本发明循疏肝解郁、补养心脾、宁志安神之理,合理选择药材,严格依照药性炮制,吸收效果佳,达到强健肝腑机能,舒缓神经紧张度的目的,经临床验证对神经衰弱有显著疗效,治愈率较高。
Description
所属技术领域
本发明涉及中药领域,尤其涉及一种用于治疗神经衰弱的丸剂及制备方法。
背景技术
神经衰弱是一类精神容易兴奋和脑力容易疲乏、常有情绪烦恼和心理生理症状的神经症性障碍,是由于大脑神经活动长期处于紧张状态,导致大脑兴奋与抑制功能失调而产生的一组以精神易兴奋、脑情绪不稳定等症状为特点的神经功能性障碍。神经衰弱的特征是易兴奋,易激惹,易衰竭,常瘵有失眠、头痛、抑郁、注意力涣散、记忆力减退和情感脆弱等。抑郁心境可导致思维消极、悲观与自责、自卑,犹如带着有色眼镜看世界,感到任何事情都困难重重,对前途悲观绝望,典型表现是行动迟缓,精力减退,缺乏兴趣和活力,总感到心有余而力不足,伴随着躯体上还有食欲减退、体重下降、性欲减退、便秘、阳痿、闭经、乏力等,严重影响了患者的正常生活,严重者甚至会导致患者自杀等极端行为的出现。
现代医学认为是超负荷的体力或脑力劳动引起大脑皮层兴奋和抑制功能紊乱,而产生神经衰弱综合征,一般采用的治疗方法包括口服复方苯巴比妥溴化钠,辅以物理治疗、针灸治疗等,治疗的效果几乎完全取决于患者心理的自行调节,目前尚无疗效好的针对性治疗方法。
传统中医理论认为,神经衰弱症主要由七情所致,由于忧思郁怒,肝失条达,气机不畅而致肝气郁结。张仲景在《金匮要略》中指出:“见肝之病,知肝传脾气。”起因由情志所伤,肝气滞郁,故见胸闷,两胁胀痛。肝气犯脾,脾失健运,故不欲饮食。脾虚生化之源不足,故体卷乏力,面色萎黄。脾虚心失所养,故心悸健忘,多梦易想。心想则阴血不足,阴不敛阳,故失眠。
本发明循疏肝解郁,补养心脾,宁志安神之理,选用通络活血、消炎镇痛、镇静安眠作用的中药材,依其药性分别炮制,强健肝腑机能,养心志,安神思,达到调节神经系统和内分泌系统使其归源的功效。
发明内容
本发明提供了一种用于治疗神经衰弱的丸剂,具有疏肝解郁、补养心脾、宁志安神、通络活血、消炎镇痛的功效,对治疗神经衰弱官能症具有很好的疗效。
为实现上述目的,本发明的技术方案实施如下:
一种用于治疗神经衰弱的丸剂,制成所述丸剂有效成分的原料组成及重量份数为:
甘草45~65份 法半夏45~60份 百合40~60份 玄参35~55份
黄莲35~50份 紫苏叶30~50份 合欢皮30~45份 莲肉25~45份
丹参25~40份 夜交藤20~40份 淮小麦20~35份 珍珠母20~30份
夏枯草15~30份 肉桂15~25份 酸枣仁10~25份 钩藤5~20份
制成所述丸剂有效成分的原料组成及重量份数为:
甘草50~60份 法半夏48~58份 百合45~55份 玄参38~52份
黄莲36~48份 紫苏叶34~46份 合欢皮32~42份 莲肉28~42份
丹参26~38份 夜交藤24~36份 淮小麦22~32份 珍珠母22~28份
夏枯草18~28份 肉桂16~22份 酸枣仁12~20份 钩藤7~16份
制成所述丸剂有效成分的原料组成及重量份数为:
甘草53份 法半夏50份 百合48份 玄参42份
黄莲40份 紫苏叶38份 合欢皮35份 莲肉33份
丹参30份 夜交藤28份 淮小麦25份 珍珠母23份
夏枯草20份 肉桂18份 酸枣仁15份 钩藤9份
一种用于治疗神经衰弱的丸剂的制备方法,包括以下工艺步骤:
(1)将珍珠母用武火煅烧至酥脆,放凉后研末,过120目细粉,备用。
(2)将百合同炼蜜混合后翻炒至不粘手,粉碎研末,过100目细粉,备用。
(3)将法半夏、丹参、淮小麦、酸枣仁用文火炒至表面黄色而微具焦斑,研末,过120目细粉,备用。
(4)将甘草、黄莲、紫苏叶、合欢皮、莲肉、夜交藤、夏枯草放入容器中,加入八倍量的水,浸泡6~8小时后,取浸液;在剩余的药渣内再加入六倍量的水,浸泡4~6小时后,取浸液;合并两次所得浸液,浓缩为60℃环境下相对密度1.15~1.25的稠膏,备用。
(5)将钩藤、玄参、肉桂放入容器中,加入四倍量的即墨老酒,煮沸后继续浸泡2~3小时,取浸液;在剩余的药渣内再加入两倍量的即墨老酒,室温环境下浸1~2小时,取浸液;合并两次所得浸液,浓缩为室温环境下相对密度1.20~1.25的稠膏,备用。
(6)将步骤(1)、步骤(2)、步骤(3)所得的细粉,与步骤(4)、步骤(5)制得的稠膏混合,搅拌均匀后加入黄油,快速冻干成粉后,制备为0.15g~0.2g/粒的丸剂产品。
本发明所用中药的药性如下:
甘草:味甘;性平。归心;肺;脾;胃经。神脾益气;清热解毒;祛痰止咳;缓急止痛;调和诸药。主治脾胃虚弱;倦怠乏力;心悸气短;痈肿疮毒;缓解药物毒性。《本草纲目》载:“诸药中甘草为君。治七十二种乳石毒,解一千二百般草本毒,调和从药有功。”现代医学研究证实,甘草有较强的解毒作用,还有抗溃疡、抗炎症、镇痉镇咳、降血压、降血脂、抗癌作用,广泛用于治疗咽喉炎、喉炎、气管炎、支气管炎、哮喘、咳嗽、咳血等疾病,此外还具有抗胃溃疡、抗胃炎作用。
法半夏:性辛、温,微寒,熟温。入脾、胃经。燥湿化痰,降逆止哎,消痞散结,外消痈肿。《别录》载:“消痈肿,疗萎黄,悦泽面目”。现代医学研究证实,法半夏含挥发油、少量脂肪、多种氨基酸、麻黄碱和葫芦巴碱,以及半夏蛋白I,对动物实验性肿瘤和Hela细胞都有明显的抑制作用,能明显促使癌细胞逐渐脱落而使癌体缩小或消失,局部清洁作用明显。
百合:味甘;微苦。性微寒。入心;肺经。养阴润肺;清心安神。主治阴虚久嗽;痰中带血;热病后期;余热未清;或情志不遂所致的虚烦惊悸;失眠多梦;精神恍惚;痈肿。《日华子本草》载:“安心,定胆,益志,养五脏。治癫邪啼位、狂叫,惊悸,杀蛊毒气,燲乳痈、发背及诸疮肿,并治产后血狂运。”现代医学研究证实,百合有良好的止咳作用,并可增加肺脏内血液的灌流量,改善肺部功能,此外还有一定的镇静作用,有安心、定胆、益智、润肺功能。
玄参:味甘;苦;咸;性微寒。归肺;胃;肾经。清热凉血;滋阴降火;解毒散结。主治温热病热和营血;身热;烦渴;舌绛;发斑;骨蒸劳嗽;虚烦不寤;津伤便秘;目涩昏花;咽喉肿痛;瘰疬痰核;痈疽疮毒。《日华子本草》载:“治头风热毒游风,补虚劳损,心惊烦躁,劣乏骨蒸,传尸邪气,止健忘,消肿毒。”现代医学研究证实,玄参含玄参素、环烯醚萜甙类,还含挥发油、生物碱等,水浸液、醇浸液和煎剂都有降低血压的作用,扩张血管、强心,此外还有镇表和抗惊厥作用。
黄莲:味苦;性寒。归心;脾;胃;肝;胆;大肠经。清热燥湿;泻火争毒。用于湿热痞满,呕吐吞酸;泻痢;黄疸;高热神昏;心火亢盛;心烦不寐;血热吐衄;目赤;牙痛;消渴;痈肿疔疮;外治湿疹;湿疮;耳道流脓。现代医学研究证明,黄莲有较强的抗微生物及抗原虫作用,可降低血溏,抗血小板聚集及溶栓,此外对鼻咽癌和宫颈癌也有抑制作用。
紫苏叶:味辛;性温。归肺;脾;胃经。散寒解表;宣肺化痰;行气和中;安胎;角鱼蟹毒。主治风寒表证;咳嗽痰多;脘胀满;恶心呕吐;腹痛吐泻;胎气不和;妊娠恶阴;食鱼蟹中毒。《本草汇言》载:“散寒气,清肺气,宽中气,安胎气,下结气,化痰气,乃治气之神药也。”现代医学研究表明,苏叶水提液可缩短血凝时间、血浆复钙时间和凝血活酶时间,促进肠蠕动,此外还有解热、抑菌、升血糖和镇静作用。
合欢皮:味甘;性平。入心;肝经。安神解郁;活血消痈。主治心神不安;忧郁;不眠;内外痈疡;跌打损伤。《本草汇言》载:“全欢皮,甘温平补,有开达五神,消除五志之妙也,味甘气平,主和缓心气,神明自畅而欢乐无忧,亦能补心脾,生血脉。”
莲肉:味甘;涩;性平。入心;脾;肾;胃;肝;膀胱经。补脾止泻;益肾固精;养心安神。主治脾虚久泻;泻久痢;肾虚遗粗;滑泄;小便不禁;妇人崩漏带下;心神不宁;惊悸;不眠。《纲目》载:“交心肾,厚肠胃,固精气,强筋骨,补虚损,利耳目,除寒湿,止脾泄,主补中,养神,益气力。”
丹参:味苦;性微寒;无毒。入心;肝经。活血调经;祛瘀止痛;凉血消痈;清心除烦;养血安神。主治心腹邪气;寒热积聚;风邪留热。《本经》载:“主心腹邪气,寒热积聚;破症除瘕,止烦满,益气。”现代医学研究证实,丹参能提高纤溶酶活性,延长出、凝血时间,抑制血小板聚集,扩张冠脉和外周血管,增加心肌血流量,促进组织的修复与再生,促进纤维母细胞分化和胶原纤维的形成,抑制细胞内原性胆固醇的合成。
夜交藤:味甘;微苦;性平。入心;肝经。养心安神;祛风;通络。主治失眠;多梦;血虚身痛;肌肤麻木;风湿痹痛;风疹瘙痒。《饮片新参》载:“养肝肾,止虚汗,安神催眠,补中气,行经络,通血脉,治劳伤。”现代医学研究证实,夜交藤含有大黄素、大黄素甲醚,与戊巴比妥钠呈协同作用,有显著的镇静、催眠作用,尤其是延长慢波睡眠时相。
淮小麦:味甘;性平。入心经。养心安神。主治神志不宁;失眠等症。《金匮要略》载:“治脏躁,能敛虚汗,并有益气、养心、除热功用,可用于阴虚发热,骨蒸劳热等证。”淮小麦善于养心以宁神志,对于神志失常以及夜寐不安等心神不宁之症,常配合甘草、大枣同用,有养心安神作用。
珍珠母:味咸;性寒。归肝;心经。平肝潜阳;安神定惊;清肝明目。主治平肝;潜阳;定惊;止血;头眩;耳鸣;心悸;失眠;癫狂;惊痫;吐血;衄血。《中国医学大辞典》载:“滋肝阴,清肝火,治癫狂惊痫,兼入心、肝两经,涉神志病者,非此不可。”现代医学研究证实,珍珠母富含碳酸钙、磷酸镁、磷酸钙、角蛋白和多种微量元素,对肝损伤有保护作用,加快谷丁转氨酶的恢复,抑制肠管收缩,增大心跳振幅,有镇静安神作用。
夏枯草:味苦;辛;性寒。归肝;胆经。清肝明目;散结解毒。主治目亦羞明;目珠疼痛;头痛眩晕;耳鸣;瘰疬;瘿瘤;乳痈;痄腮;痈疖肿毒;急慢性肝炎;高血压病。《滇南本草》载:“祛肝风,行经络。治口眼歪斜,行肝气,开肝郁,止筋骨疼痛,目珠痛,散瘰疬,周身结核。”现代医学研究证实,夏枯草有明显的降血糖、血压、血脂,抗菌及抗病毒作用,广谱抗菌、抗突变,对早期炎症反应有显著的抵制作用,调节中枢神经功能。
肉桂:味辛;苦;性热。入肾;脾;心;肝经。补火助阳;引火归源;
散寒止痛;温经通脉。主治肾阳不足;命门火畏寒肢冷;腰膝酸软;阳痿遗精;短气喘促;浮肿尿少诸证;命门火衰;火不归源;戴阳;格阳;及上热下寒;面赤足冷;头晕耳鸣;口舌糜破;脾肾虚寒;脘腹冷痛;食减便溏;肾虚腰痛;寒湿痹痛;寒疝疼痛。《药性论》载:“主治九种心痛,杀三虫,主破血,治软脚,痹、不仁,除咳逆,结气、拥痹,止腹内冷气,痛不可忍。”现代医学研究证实,肉桂含有肉桂醛、醋酸肉桂酯、醋酸苯基丙酪等成分,具有芳香健胃、解热镇痛、抗菌消炎的作用。
酸枣仁:味甘;性平。归心;脾;肝;胆经。宁心安神;养肝;敛汗。主治虚烦不眠;惊悸怔忡;体虚自汗;盗汗。《纲目》载:“酸枣仁,甘而润,故熟用疗胆虚不得眠,烦渴虚汗之证;生用疗胆热好眠。皆足厥阴、少阳药也,今人专以为心家药,殊昧此理。”现代医学研究证实,酸枣仁有镇静、催眠、镇痛、抗惊厥作用,阻滞心传导,扩散内抑制,减少防御性运动性条件反射次数。
钩藤:味苦;苦;性微寒。入肝;心经。清热平肝;熄风止痉。主治小儿惊风;夜啼;热盛动风;子痫;肝阳眩晕;肝火头胀痛。《本草述》载:“治中风瘫痪,口眼喎斜,及一切手足走注疼痛,肢节挛急。又治远年痛风瘫痪,筋脉拘急作痛不已者。”现代医学研究证实,钩藤内含的吲哚类生物碱,除具有降压、抗癫痫作用外,还有一定的抗焦虑作用,醇提液对中枢神经系统的突触传递过程有明显的抑制效应,增强对神经元细胞的保护。
本发明与现有技术相比,具有以下有益效果:
本发明循疏肝解郁、补养心脾、宁志安神之理,合理选择药材,严格依照药性炮制,吸收效果佳,达到强健肝腑机能,舒缓神经紧张度的目的,经临床验证对神经衰弱有显著疗效,治愈率较高。
具体实施方式
下面结合具体实施例对本发明做进一步阐述。
实施例1
本发明丸剂有效成分的原料组成及重量为:
甘草58g 法半夏55g 百合53g 玄参48g
黄莲45g 紫苏叶43g 合欢皮40g 莲肉38g
丹参35g 夜交藤33g 淮小麦30g 珍珠母28g
夏枯草25g 肉桂22g 酸枣仁19g 钩藤15g
本发明丸剂制备方法的工艺步骤为:
(1)将珍珠母用武火煅烧至酥脆,放凉后研末,过120目细粉,备用。
(2)将百合同炼蜜混合后翻炒至不粘手,粉碎研末,过100目细粉,备用。
(3)将法半夏、丹参、淮小麦、酸枣仁用文火炒至表面黄色而微具焦斑,研末,过120目细粉,备用。
(4)将甘草、黄莲、紫苏叶、合欢皮、莲肉、夜交藤、夏枯草放入容器中,加入八倍量的水,浸泡6~8小时后,取浸液;在剩余的药渣内再加入六倍量的水,浸泡4~6小时后,取浸液;合并两次所得浸液,浓缩为60℃环境下相对密度1.15~1.25的稠膏,备用。
(5)将钩藤、玄参、肉桂放入容器中,加入四倍量的即墨老酒,煮沸后继续浸泡2~3小时,取浸液;在剩余的药渣内再加入两倍量的即墨老酒,室温环境下浸1~2小时,取浸液;合并两次所得浸液,浓缩为室温环境下相对密度1.20~1.25的稠膏,备用。
(6)将步骤(1)、步骤(2)、步骤(3)所得的细粉,与步骤(4)、步骤(5)制得的稠膏混合,搅拌均匀后加入黄油,快速冻干成粉后,制备为0.15g~0.2g/粒的丸剂产品。
用法用量:每日3次,每次5丸,饭前或饭后两小时以温开水送服,7天为一个疗程,重症者每日4次,每次5~8丸。
实施例2
本发明丸剂有效成分的原料组成及重量为:
甘草55g 法半夏53g 百合50g 玄参45g
黄莲42g 紫苏叶40g 合欢皮37g 莲肉35g
丹参32g 夜交藤30g 淮小麦27g 珍珠母25g
夏枯草23g 肉桂19g 酸枣仁16g 钩藤12g
本实施例的药丸制备方法工艺步骤及用法用量与实施例1相同。
实施例3
本发明丸剂有效成分的原料组成及重量为:
甘草53g 法半夏50g 百合48g 玄参42g
黄莲40g 紫苏叶38g 合欢皮35g 莲肉33g
丹参30g 夜交藤28g 淮小麦25g 珍珠母23g
夏枯草20g 肉桂18g 酸枣仁15g 钩藤9g
本实施例的药丸制备方法工艺步骤及用法用量与实施例1相同。
临床资料:
经临床神经衰弱官能综合症患者治疗情况跟踪统计,表明本发明所述药丸疗效显著,在38例神经衰弱重度症状患者中,治愈率达44.2%,总有效率达92.1%;在46例神经衰弱轻度症状患者中,治愈率达85.7%,总有效率达95.3%,可作为神经衰弱临床主要治疗药物使用。
Claims (4)
1.一种用于治疗神经衰弱的丸剂,其特征在于:制成所述丸剂有效成分的原料组成及重量份数为:
甘草45~65份 法半夏45~60份 百合40~60份 玄参35~55份
黄莲35~50份 紫苏叶30~50份 合欢皮30~45份 莲肉25~45份
丹参25~40份 夜交藤20~40份 淮小麦20~35份 珍珠母20~30份
夏枯草15~30份 肉桂15~25份 酸枣仁10~25份 钩藤5~20份。
2.根据权利要求1所述的一种用于治疗神经衰弱的丸剂,其特征在于:制成所述丸剂有效成分的原料组成及重量份数为:
甘草50~60份 法半夏48~58份 百合45~55份 玄参38~52份
黄莲36~48份 紫苏叶34~46份 合欢皮32~42份 莲肉28~42份
丹参26~38份 夜交藤24~36份 淮小麦22~32份 珍珠母22~28份
夏枯草18~28份 肉桂16~22份 酸枣仁12~20份 钩藤7~16份。
3.根据权利要求1所述的一种用于治疗神经衰弱的丸剂,其特征在于:制成所述丸剂有效成分的原料组成及重量份数为:
甘草53份 法半夏50份 百合48份 玄参42份
黄莲40份 紫苏叶38份 合欢皮35份 莲肉33份
丹参30份 夜交藤28份 淮小麦25份 珍珠母23份
夏枯草20份 肉桂18份 酸枣仁15份 钩藤9份。
4.一种如权利要求1-3任一项所述的用于治疗神经衰弱的丸剂的制备方法,其特征在于:包括以下工艺步骤:
(1)将珍珠母用武火煅烧至酥脆,放凉后研末,过120目细粉,备用;
(2)将百合同炼蜜混合后翻炒至不粘手,粉碎研末,过100目细粉,备用;
(3)将法半夏、丹参、淮小麦、酸枣仁用文火炒至表面黄色而微具焦斑,研末,过120目细粉,备用;
(4)将甘草、黄莲、紫苏叶、合欢皮、莲肉、夜交藤、夏枯草放入容器中,加入八倍量的水,浸泡6~8小时后,取浸液;在剩余的药渣内再加入六倍量的水,浸泡4~6小时后,取浸液;合并两次所得浸液,浓缩为60℃环境下相对密度1.15~1.25的稠膏,备用;
(5)将钩藤、玄参、肉桂放入容器中,加入四倍量的即墨老酒,煮沸后继续浸泡2~3小时,取浸液;在剩余的药渣内再加入两倍量的即墨老酒,室温环境下浸1~2小时,取浸液;合并两次所得浸液,浓缩为室温环境下相对密度1.20~1.25的稠膏,备用;
(6)将步骤(1)、步骤(2)、步骤(3)所得的细粉,与步骤(4)、步骤(5)制得的稠膏混合,搅拌均匀后加入黄油,快速冻干成粉后,制备为0.15g~0.2g/粒的丸剂产品。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210483874.8A CN102935185B (zh) | 2012-11-25 | 2012-11-25 | 一种用于治疗神经衰弱的丸剂及制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210483874.8A CN102935185B (zh) | 2012-11-25 | 2012-11-25 | 一种用于治疗神经衰弱的丸剂及制备方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102935185A CN102935185A (zh) | 2013-02-20 |
| CN102935185B true CN102935185B (zh) | 2014-04-16 |
Family
ID=47694132
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201210483874.8A Expired - Fee Related CN102935185B (zh) | 2012-11-25 | 2012-11-25 | 一种用于治疗神经衰弱的丸剂及制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102935185B (zh) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103735822A (zh) * | 2013-12-12 | 2014-04-23 | 刘磊 | 一种治疗神经衰弱的中药配方 |
| CN104258118A (zh) * | 2014-09-12 | 2015-01-07 | 灌阳千家洞瑶之源生物科技有限公司 | 一种养心安神的瑶药组合物及其制备方法 |
| CN106259212A (zh) * | 2016-08-11 | 2017-01-04 | 安徽泰益生物科技有限公司 | 一种抗应激水蛭捕捞剂 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101653579A (zh) * | 2009-05-20 | 2010-02-24 | 北京国奥健康科技研究院 | 治疗顽固性失眠的中药制剂 |
-
2012
- 2012-11-25 CN CN201210483874.8A patent/CN102935185B/zh not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101653579A (zh) * | 2009-05-20 | 2010-02-24 | 北京国奥健康科技研究院 | 治疗顽固性失眠的中药制剂 |
Non-Patent Citations (2)
| Title |
|---|
| 王少墨等.神经衰弱的中医治疗近展.《辽宁中医杂志》.2004,(第03期), |
| 神经衰弱的中医治疗近展;王少墨等;《辽宁中医杂志》;20040318(第03期);262 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102935185A (zh) | 2013-02-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105615443A (zh) | 一种改善睡眠的药枕 | |
| CN105194565A (zh) | 一种用于治疗心脏神经症的中药丸剂及制备方法 | |
| CN104825801A (zh) | 一种预防和治疗心脑血管疾病的中药制剂 | |
| CN103316146B (zh) | 一种麻醉用中药制剂 | |
| CN103749824B (zh) | 一种绞股蓝降糖降压保健茶及其制备方法 | |
| CN104069474A (zh) | 一种治疗脂溢性脱发的中药组合物及其制备方法 | |
| CN102935185B (zh) | 一种用于治疗神经衰弱的丸剂及制备方法 | |
| CN102908474B (zh) | 一种治疗神经官能症的药酒 | |
| CN105056133A (zh) | 一种用于治疗纤维肌痛综合症的中药丸剂及制备方法 | |
| CN104721628A (zh) | 一种用于脑震荡康复治疗的中药药丸及制备方法 | |
| CN104623433A (zh) | 一种预防麻醉后寒战的中药药物及其制备方法 | |
| CN107137499A (zh) | 一种调理身体补充元气的热敷粉包 | |
| CN103920058A (zh) | 一种治疗头痛的中药制剂及其制备方法 | |
| CN104825956A (zh) | 防治中风、康复筋骨关节的药 | |
| CN103239556B (zh) | 一种治疗风寒湿痹引发的颈椎病的中药 | |
| CN103844164A (zh) | 一种益气补血粥及其制备方法 | |
| CN105998555A (zh) | 一种用于产后关节痛缓解与护理的中药丸剂及制备方法 | |
| CN102935156B (zh) | 一种治疗骨质增生症的丸剂 | |
| CN103446310B (zh) | 一种治疗腰腿痛的中药药浴及其制备方法 | |
| CN101518579B (zh) | 一种稳压疏通药及制备工艺 | |
| CN104800610A (zh) | 一种治疗帕金森病的中药制剂及其制备方法 | |
| CN104173775A (zh) | 颈源性头痛中药组合物及制备方法 | |
| CN104189714A (zh) | 一种治疗冠心病的中药胶囊 | |
| CN104771734B (zh) | 一种治疗慢性肺心病的中药组合物 | |
| CN103623361A (zh) | 用于治疗脑血栓的中药组合物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140416 Termination date: 20141125 |
|
| EXPY | Termination of patent right or utility model |